Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

High Intensity Statin Therapy With Crestor May Reverse Atherosclerosis, JAMA Study Finds

This article was originally published in The Pink Sheet Daily

Executive Summary

ASTEROID trial smashes previous records for LDL-cholesterol level decreases and HDL increases achieved in previous statin trials.
Advertisement

Related Content

AstraZeneca To File For Additional Crestor Claim In First Half 2007
AstraZeneca To File For Additional Crestor Claim In First Half 2007
Lower LDL-Cholesterol Levels To Be Topic Of NIH Study
Lower LDL-Cholesterol Levels To Be Topic Of NIH Study
Lipitor, Pravachol Comparison Studies May Cloud OTC Switch Prospects For Statins
Lipitor, Pravachol Comparison Studies May Cloud OTC Switch Prospects For Statins

Topics

Advertisement
UsernamePublicRestriction

Register

PS063825

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel